Infervision

With A.l., We Improve Human Life

In 2019, Infervision is planning to continue our global expansion in order to maintain a solid first-tier position in the medical imaging AI field.

这是描述信息

Our work and mission

About Infervision

Beijing Infervision Technology Co., Ltd. is a world's leading high-tech enterprise in medical artificial intelligence. Aiming to empower doctors for higher efficiency and benefit patients with better diagnosis and lower cost, Infervision is using A.I. and deep learning technologies to develop multi-scheme platforms, including A.I. deployment management platform, A.I. data mining research platform, and A.I. clinical application platform.

Currently, Infervision is helping physicians with over 40,000 clinical diagnoses every day, and has processed over a total of seven million cases. Infervision’s medical A.I. products are rapidly becoming the highly-scaled quality control system worldwide.

AI Solutions

InferRead  ®Solutio

Infervision products are designed using the most advanced deep learning algorithms, Convolutional Neural Network (CNN), to mimic the human cognitive functioning. 

01

02

InferScholar  ®Center

Infervision products are designed using the most advanced deep learning algorithms, Convolutional Neural Network (CNN), to mimic the human cognitive functioning. 

InferSight  ®Data Analytics

Infervision products are designed using the most advanced deep learning algorithms, Convolutional Neural Network (CNN), to mimic the human cognitive functioning. 

03

AI Solutions · We provide professional solutions

Key Features

 Infervision has domestic service-sites covering 32 provincial regions, with the presence in eight countries worldwide. 

服务特色

User-friendliness

Seamless integration into physician’s

daily workflow

服务特色

Robustness

Fit for all varieties of application

scenarios

服务特色

Safety

Assured security to the data internet,

and business

Our Stories

Our is helping physicians with over 53,000 clinical diagnoses every day, and has processed over a total of seventeen million cases.

Infervision Receives FDA Clearance for the InferRead Lung CT.AI
2020-07-13

Infervision Receives FDA Clearance for the InferRead Lung CT.AI

Infervision's newly FDA approved CT lung AI application sets a new standard
VIEW MORE
Announcing Infervision
2020-06-10

Announcing Infervision's New Brand Identity

We are pleased to announce the launch of our new brand identity, including our new logo! Our current branding has been performing well for the past 5 years, but now it's time to go to the next level.
VIEW MORE
AlgoMedica and InferVision establish partnership to Improve the performance of medical imaging AI software to Identify COVID-19
2020-05-18

AlgoMedica and InferVision establish partnership to Improve the performance of medical imaging AI software to Identify COVID-19

Infervision is excited to partner with AlgoMedica to maximize the performance of the AI tools fighting COVID-19
VIEW MORE

InferVision North America

1900 Market Street, Fl 8th, Philadelphia, PA 19103

 

usa@infervision.com

InferVision Europe

Mainzer Straße 75, 65189 Wiesbaden, Germany

 

europe@infervision.com

InferVision China

18 / f, seat E, ocean international center, chaoyang district, Beijing

 

contact@infervision.com

InferVision APAC

30/F Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 163-1030

 

apac@infervision.com

+81(0)3-6256-9810

Copyright © 2019   Beijing Infervision Technology Co., Ltd.  All Rights Reserved.